tybost
gilead sciences ireland uc - cobicistat - hiv-infektionen - antivirale mittel zur systemischen anwendung - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
vemlidy
gilead sciences ireland uc - tenofoviralafenamidfumarat - hepatitis b - antivirale mittel zur systemischen anwendung - vemlidy is indicated for the treatment of chronic hepatitis b (chb) in adults and paediatric patients 6 years of age and older weighing at least 25 kg (see section 5.
sovaldi
gilead sciences ireland uc - sofosbuvir - hepatitis c, chronisch - antivirale mittel zur systemischen anwendung - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 und 5. für hepatitis-c-virus (hcv) genotyp spezifische aktivität, siehe abschnitte 4. 4 und 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 und 5. für hepatitis-c-virus (hcv) genotyp spezifische aktivität, siehe abschnitte 4. 4 und 5.
truvada
gilead sciences ireland uc - emtricitabin, tenofovir disoproxil fumarate - hiv-infektionen - antivirale mittel zur systemischen anwendung - treatment of hiv-1 infection: , truvada is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults. , truvada ist auch indiziert für die behandlung von hiv-1-infizierten jugendlichen, der mit nrti-resistenz oder-toxizitäten unter ausschluss der nutzung von first-line-agenten, im alter von 12 bis < 18 jahren. , pre-exposure prophylaxis (prep): , truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk.
ambisome pulver zur herstellung einer infusionsdispersion
gilead sciences switzerland sàrl - amphotericinum b - pulver zur herstellung einer infusionsdispersion - praeparatio cryodesiccata: amphotericinum b 50 mg, phosphatidylcholinum ex soja hydrogenatum, cholesterolum, distearoylphosphatidylglycerolum natricum, int-rac-alpha-tocopherolum, saccharum, dinatrii succinas hexahydricus, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium max. 8.5 mg. - antimykotikum - synthetika
vosevi
gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitis c, chronisch - antivirale mittel zur systemischen anwendung - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (siehe abschnitt 4. 2, 4. 4 und 5.
biktarvy
gilead sciences ireland uc - bictegravir, emtricitabin, tenofovir alafenamide, fumarate - hiv-infektionen - antivirale mittel zur systemischen anwendung - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (siehe abschnitt 5.
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale mittel zur systemischen anwendung - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
trodelvy 180 mg pulver für ein konzentrat zur herstellung einer infusionslösung
gilead sciences switzerland sàrl - sacituzumabum govitecanum - pulver für ein konzentrat zur herstellung einer infusionslösung - praeparatio cryodesiccata: sacituzumabum govitecanum 180 mg, acidum morpholinoethansulfonicum, trehalosum dihydricum, polysorbatum 80, pro vitro. - mammakarzinom - biotechnologika